Professional background
Mr Ciaran Hill is a consultant neurosurgeon specialising in the treatment of brain tumours. He is based at the National Hospital for Neurology and Neurosurgery, Queen Square, and the UCL Cancer Institute in London.
He delivers care within a specialist multidisciplinary team, ensuring that surgical, radiotherapy, and medical treatment options are considered in a coordinated and evidence-based way. His practice focuses on maximising tumour treatment while preserving neurological function and quality of life.
His surgical practice emphasises function-preserving surgery. This includes awake craniotomy and intraoperative brain mapping to protect critical functions such as speech and movement. Where appropriate, he uses minimally invasive approaches to reduce tissue disruption and support recovery, with attention to surgical planning and cosmetic outcomes. He also offers stereotactic radiosurgery, including Gamma Knife treatment, as a non-invasive option where appropriate.
Mr Hill trained at Barts and The Royal London Medical School, graduating top of his year with a double distinction. He completed specialist neurosurgical training in London. He holds a master's degree in clinical neuroscience (distinction) from UCL and a PhD from the University of Cambridge.
He leads a translational research programme focused on the biology of brain tumours and the development of new treatments. This informs his clinical practice and supports consideration of emerging therapies and clinical trials where appropriate. He is an honorary associate professor at University College London and has published widely in neuro-oncology.
He holds national roles in neurosurgery and neuro-oncology and contributes to the design and delivery of clinical and translational studies. He also holds senior leadership roles in clinical governance and medical education, with responsibility for patient safety and the training of neurosurgeons.
In addition to neuro-oncology, he treats selected other intracranial conditions.
Specialties
Research interests
- Molecular biology of brain tumours
- Translation of new therapies into clinical care